Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAM Device and Diclofenac for Knee Osteoarthritis Pain
NCT05882812Phase 2Completed
- Start
- Jun 2023
- Primary completion
- Dec 2023
- Countries
- 1
01
Overview
Phase 2, randomised trial (3 arms). Primary endpoints: Change in Pain Units on a Scale (0-10) at 8 weeks and Change in the Western Ontario and McMaster Universities Osteoarthritis Index at 8 weeks. Started Jun 2023; status: completed.
Beyond the preview
Go deeper on NCT05882812.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05882812.